Navidea Biopharma (AMEX: NAVB) announced that an analysis comparing sentinel lymph node (SLN) biopsy procedures using Lymphoseek (technetium Tc 99m ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE